Clinical aspects of Alzheimer's disease

被引:23
|
作者
Bianchetti, A [1 ]
Trabucchi, M [1 ]
机构
[1] Geriatr Res Grp, Brescia, Italy
关键词
Alzheimer's disease; AD clinical course; cognitive impairment; functional impairment;
D O I
10.1007/BF03351480
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Alzheimer's disease (AD) is the most common of the dementing disorders. AD begins insidiously and progresses gradually; it is characterized clinically not only by an impairment in cognition, but also by a decline in global function, a deterioration in the ability to perform activities of daily living, and the appearance of behavioral disturbances. No definitive tests for the diagnosis are available, and AD is a diagnosis of inclusion based on patient history, physical examination, neuropsychological testing, and laboratory studies. Disease progression is highly variable, and median survival after the onset of dementia ranges from 5 to 9.3 years. Early recognition of AD allows time to plan for the future, and to treat patients before marked deterioration occurs. (C) 2001, Editrice Kurtis.
引用
收藏
页码:221 / 230
页数:10
相关论文
共 50 条
  • [41] Cognitive aspects of attention deficits in Alzheimer's disease
    Sieroff, Eric
    Joly, Charlotte
    Lenoir, Henri
    GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT, 2020, 18 (04): : 419 - 428
  • [42] Dysgraphia in Alzheimer's disease: A review for clinical and research purposes
    Neils-Strunjas, Jean
    Groves-Wright, Kathy
    Mashima, Pauline
    Harnish, Stacy
    JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH, 2006, 49 (06): : 1313 - 1330
  • [43] Association between clinical dementia rating and clinical outcomes in Alzheimer's disease
    Lanctot, Krista L.
    Boada, Merce
    Tariot, Pierre N.
    Dabbous, Firas
    Hahn-Pedersen, Julie
    Udayachalerm, Sariya
    Raket, Lars Lau
    Saiontz-Martinez, Cynthia
    Michalak, Wojciech
    Weidner, Wendy
    Cummings, Jeffrey
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2024, 16 (01)
  • [44] Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations
    Petersen, Ronald C.
    Graf, Ana
    Brady, Chris
    De Santi, Susan
    Florian, Hana
    Landen, Jaren
    Pontecorvo, Mike
    Randolph, Christopher
    Sink, Kaycee M.
    Carrillo, Maria C.
    Weber, Christopher J.
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2023, 9 (04)
  • [45] Clinical methodology of Alzheimer's disease trials
    Gray, JA
    DRUG INFORMATION JOURNAL, 1999, 33 (01): : 245 - 252
  • [46] Pathology of clinical and preclinical Alzheimer’s disease
    Dietmar Rudolf Thal
    Christine von Arnim
    W. Sue T. Griffin
    Haruyasu Yamaguchi
    Robert E. Mrak
    Johannes Attems
    Ajeet Rijal Upadhaya
    European Archives of Psychiatry and Clinical Neuroscience, 2013, 263 : 137 - 145
  • [47] Alzheimer’s Disease: Epidemiology and Clinical Progression
    Amir Abbas Tahami Monfared
    Michael J. Byrnes
    Leigh Ann White
    Quanwu Zhang
    Neurology and Therapy, 2022, 11 : 553 - 569
  • [48] Clinical update on Alzheimer's disease immunotherapies
    Grundman, Michael
    NEUROBIOLOGY OF AGING, 2008, 29 : S11 - S11
  • [49] Clinical Trials and Alzheimer's Disease: A Webliography
    Howard, Allison
    JOURNAL OF CONSUMER HEALTH ON THE INTERNET, 2014, 18 (01) : 67 - 80
  • [50] Clinical Methodology of Alzheimer’s Disease Trials
    Julian A. Gray
    Drug information journal : DIJ / Drug Information Association, 1999, 33 (1): : 245 - 252